This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.
Centene (CNC) Up 4.8% on Upbeat '22 Guidance: Key Details
by Zacks Equity Research
Centene (CNC) expects bottom-line growth to be supported by lower expenses and gross margin improvement.
Cigna (CI) Offers MA Plans in Florida, Boosts Provider Network (Revised)
by Zacks Equity Research
Cigna (CI) announces that it will offer affordable MA plans in two new counties of Florida. Concurrently, CI includes HCA Healthcare to provide a boost to its provider network.
Humana (HUM) Ties Up to Enhance Medicare Advantage Business
by Zacks Equity Research
Humana (HUM) forges an alliance with the Loudoun Medical Group to boost its Medicare Advantage portfolio.
Cigna (CI) Offers MA Plans in Florida, Boosts Provider Network
by Zacks Equity Research
Cigna (CI) announces that it will offer affordable MA plans in two new counties of Florida. Concurrently, CI includes HCA Healthcare to provide a boost to its provider network.
UnitedHealth (UNH) Ups Guidance: Here's What You Should Know
by Zacks Equity Research
UnitedHealth's (UNH) 2022 bottom line estimates are below the Zacks Consensus Estimate, may be due to an uptick in insurance claims triggered by the coronavirus pandemic.
Centene (CNC) Up 7.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Centene (CNC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Humana (HUM) to Provide Value-Based Care in Central Kansas
by Zacks Equity Research
Humana (HUM) expands the value-based agreement with Hutchinson Clinic in a bid to provide enhanced healthcare services to its MA members in central Kansas.
Humana (HUM) Ties Up With Allina Health to Boost Value-Based Care
by Zacks Equity Research
Humana (HUM) expands value-based agreement with Allina Health, which is aimed at offering enhanced outcomes for HUM's MA members in Minnesota.
Tenet Healthcare (THC) Offers Senior Secured Notes of $1.45B
by Zacks Equity Research
Tenet Healthcare (THC) issues senior notes to procure funds. The move further highlights THC's sound financial position.
Molina Healthcare (MOH) Offers $750M, 3.875% Senior Notes
by Zacks Equity Research
Molina Healthcare (MOH) shows discretion in issuing senior notes amid a low-interest rate environment, which in turn, will procure funds.
Anthem (ANTM) to Acquire Integra to Enhance Medicaid Business
by Zacks Equity Research
Anthem (ANTM) to buy Integra Managed Care from a wholly-owned indirect unit of Personal Touch Holding Corporation to bolster its Medicaid Business profile.
Magellan (MGLN) Q3 Earnings Decline Y/Y on Elevated Costs
by Zacks Equity Research
Magellan Health's (MGLN) third-quarter results reflect impact of rising expenses, partly offset by top-line growth and net new business growth in the Healthcare segment.
Centene's (CNC) Q3 Earnings Miss Estimates, Revenues Up Y/Y
by Zacks Equity Research
Centene's (CNC) third-quarter results reflect improved revenues, better Medicare and Medicaid membership growth, partly offset by higher SG&A costs.
Centene (CNC) Q3 Earnings Miss Estimates
by Zacks Equity Research
Centene (CNC) delivered earnings and revenue surprises of -2.33% and 1.85%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Centene (CNC) Gears Up for Q3 Earnings: What Lies Ahead?
by Zacks Equity Research
Centene's (CNC) third-quarter results are likely to reflect better revenues and membership growth.
Centene (CNC) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Centene (CNC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UnitedHealth (UNH) Beats on Q3 Earnings & Revenues, Ups View
by Zacks Equity Research
UnitedHealth (UNH) Q3 results reflect revenue growth at both the business units and increased membership.
Humana's (HUM) 2022 Expansion Plan to Boost MA Customer Base
by Zacks Equity Research
Humana (HUM) declares enhanced health plans for its customers to opt for in the 2022 Medicare AEP period. The company will foray into newer counties to offer improved health outcomes.
Centene (CNC) Expands Medicare Advantage Offerings in 36 States
by Zacks Equity Research
Centene (CNC) boosts its Medicare Advantage offerings in 1,575 counties across 36 states in a bid to provide affordable and quality healthcare.
Magellan (MGLN) Unit Launches Solution to Improve Behavioral Care
by Zacks Equity Research
Magellan's (MGLN) unit - Magellan Healthcare - together with NeuroFlow, introduces a collaborative care management solution in a bid to ease the behavioral health treatment process.
UnitedHealth (UNH) Woos MA Members With Updated 2022 Plans
by Zacks Equity Research
UnitedHealth (UNH) announces MA plans for 2022 to maintain its leadership position in the market.
3 HMO Stocks That Outperformed the S&P Index in a Year's Time
by Srijita Guha
Membership growth, mergers and buyouts, and investment in technology are likely to aid health insurance companies like ANTM, MOH, and UNH to outperform the S&P Index.
Here is Why UnitedHealth (UNH) Should Grace Your Portfolio
by Zacks Equity Research
A solid positioning in an ever-growing industry makes UnitedHealth (UNH) a top pick for strong investment gains.
Zacks Industry Outlook Highlights: UnitedHealth Group, Anthem, Humana and Centene Corp
by Zacks Equity Research
Zacks Industry Outlook Highlights: UnitedHealth Group, Anthem, Humana and Centene Corp
4 HMO Stocks in Focus as Government Backs Healthcare Reform
by Sapna Bagaria
The Health insurance industry is poised to grow on the back of a better regulatory environment. Aging demography, automation plus mergers and acquisitions are other catalysts.